Related Experiment Video
Updated: Jun 11, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Prevention of schizophrenia
Ming T Tsuang1, William S Stone, Tracey L Auster
1University of California San Diego, CA, USA. mtsuang@ucsd.edu
Expert Review of Neurotherapeutics
|July 1, 2010
Summary
Identifying schizophrenia vulnerability in genetic high-risk groups involves assessing cognitive, clinical, and social functions. This research aims to develop early intervention strategies by recognizing patterns of transition to schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Schizophrenia poses a significant public health challenge, particularly in identifying individuals at high risk.
- Genetic high-risk groups offer a unique window into the early stages of schizophrenia development.
Purpose of the Study:
- To review progress in identifying vulnerability to schizophrenia within genetic high-risk populations.
- To explore dimensions of vulnerability and novel endophenotypes for improved risk assessment.
Main Methods:
- Review of studies examining cognitive, clinical, and social functioning in at-risk individuals.
- Consideration of schizotaxia and novel endophenotypes including brain function and molecular biology.
- Integration of clinical, social, and neuropsychological measures.
Main Results:
- Vulnerability dimensions encompass cognitive, clinical, and social functions.
- Specialized programs are emerging for recognizing transition rates and patterns.
- Intervention techniques involve psychopharmacological and psychotherapeutic approaches.
Conclusions:
- Identifying novel endophenotypes can refine our understanding of schizophrenia liability.
- Validated syndromes of liability are crucial for early intervention and prevention.
- Homogenous treatment groups will facilitate the development of effective early intervention strategies.
Related Concept Videos
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...